Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00713
|
|||||
| Drug Name |
Clarithromycin
|
|||||
| Synonyms |
clarithromycin; 81103-11-9; Biaxin; Clarithromycine; Klaricid; 6-O-Methylerythromycin; Clathromycin; 6-O-Methylerythromycin a; Abbott-56268; Macladin; Veclam; Kofron; Klacid; Clarith; Clarithromycinum; Naxy; A-56268; Erythromycin, 6-O-methyl-; TE-031; Claritromicina; Fromilid; Claridar; Bicrolid; Astromen; Claricide; Clacine; Abbotic; Mabicrol; Clambiotic; Klaciped; Heliclar; Claripen; Claribid; Clarem; Clacid; Clacee; Zeclar; Maclar; Klarid; Crixan; Klarin; Klabax; Cyllid; Mavid; Helas; Biaxin filmtab; Adel; Klax; Biaxin xl filmtab; Biaxin HP; Klaricid Pe
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Bacterial infections [ICD11: 1A00-1H0Z] | Approved | [1] | |||
| Therapeutic Class |
Antibiotics
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C38H69NO13
|
|||||
| Canonical SMILES |
CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
|
|||||
| InChI |
InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
|
|||||
| InChIKey |
AGOYDEPGAOXOCK-KCBOHYOISA-N
|
|||||
| CAS Number |
CAS 81103-11-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 748 | Topological Polar Surface Area | 183 | ||
| Heavy Atom Count | 52 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 14 | |||
| XLogP |
3.2
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
CHEBI:3732
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Clarithromycin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.